company background image
46K logo

IRADIMED BST:46K Stock Report

Last Price

€59.50

Market Cap

€745.1m

7D

0%

1Y

n/a

Updated

05 Feb, 2025

Data

Company Financials +

IRADIMED CORPORATION

BST:46K Stock Report

Market Cap: €745.1m

46K Stock Overview

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. More details

46K fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 39.7% below our estimate of its fair value

Earnings are forecast to grow 15.44% per year

Earnings grew by 14.1% over the past year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

IRADIMED CORPORATION Competitors

Eckert & Ziegler

XTRA:EUZ

€1.2b

Drägerwerk KGaA

XTRA:DRW3

€953.0m

Stratec

XTRA:SBS

€434.0m

PULSION Medical Systems

MUN:PUS

€136.0m

Price History & Performance

Summary of share price highs, lows and changes for IRADIMED
Historical stock prices
Current Share PriceUS$59.50
52 Week HighUS$59.50
52 Week LowUS$37.60
Beta0.83
1 Month Change8.18%
3 Month Change15.53%
1 Year Changen/a
3 Year Change50.25%
5 Year Change157.80%
Change since IPO143.75%

Recent News & Updates

Recent updates

Shareholder Returns

46KDE Medical EquipmentDE Market
7D0%-0.8%0.3%
1Yn/a-4.9%12.9%

Return vs Industry: Insufficient data to determine how 46K performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 46K performed against the German Market.

Price Volatility

Is 46K's price volatile compared to industry and market?
46K volatility
46K Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.4%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 46K's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 46K's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992148Roger Susiwww.iradimed.com

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

IRADIMED CORPORATION Fundamentals Summary

How do IRADIMED's earnings and revenue compare to its market cap?
46K fundamental statistics
Market cap€745.11m
Earnings (TTM)€17.89m
Revenue (TTM)€68.47m

41.7x

P/E Ratio

10.9x

P/S Ratio

Is 46K overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
46K income statement (TTM)
RevenueUS$71.31m
Cost of RevenueUS$16.30m
Gross ProfitUS$55.00m
Other ExpensesUS$36.38m
EarningsUS$18.63m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)1.47
Gross Margin77.14%
Net Profit Margin26.12%
Debt/Equity Ratio0%

How did 46K perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

31%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/05 03:47
End of Day Share Price 2025/01/29 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IRADIMED CORPORATION is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lawrence SolowCJS Securities, Inc.
Frank TakkinenLake Street Capital Markets, LLC
Scott HenryRoth Capital Partners